Fredrik Lindberg
CEO
Born 1957. Appointed in Nov 2014
Education: MD, Ph.D, and an Associate Professor of Clinical Pharmacology.

Fredrik has extensive experience from the life science industry and from growth companies with international operations. Previous positions include CEO of Bone Support AB, Nordic Medical Director of Searle Pharmaceuticals, and Head of the Department of Clinical Pharmacology at the University Hospital in Lund. Member of Enzymatica’s Board 2012-feb 2015.

Ulf Blom
EVP Marketing & Operations

Born 1965. With Enzymatica since 2011.
Education: B.Sc. Economics and Business Administration.

Co-founder of Enzymatica. Ulf has over 15 years experience in various management positions in sales and marketing in the pharmaceutical industry, including Novo Nordisk, Astra Zeneca and ALK. Has extensive experience in all phases of strategic global commercialization of pharmaceutical products.

Anna Isaksson
VP Quality and Regulatory Management
Born 1973. With Enzymatica since 2015
Education: M.Sc. Industrial Engineering. Chalmers University of Technology.

Anna has over 15 years working experience in international Medtech companies such as, Gambro and ArjoHuntleigh. She has extensive experience in both product development and quality management, including management positions in these areas.

Claus Egstrand
Chief Commercial Officer
Born 1961. With Enzymatica since August 2017

Claus Egstrand's previous positions have included being Head of Europe for MSD Consumer Care in the pharmaceutical company Merck & Co, Vice President, General Manager Medsurg Europe in the medical device company Stryker Corporation,

Senior Vice President Consumer Healthcare for Latin America, Africa, Asia, Japan and Australia in the pharmaceutical company Pfizer, Vice President and head of global marketing for the smoking cessation product Nicorette in the pharmaceutical company Pharmacia and CEO of the Johnson&Johnson/Merck Pharmaceuticals' operation in France. He joins Enzymatica from a position as Group President, International at HOLOGIC CORP.

Johan Lindvall
Chief Operating Officer
Born 1970. With Enzymatica since October 2017
Education: Bachelor of Science Mechanical Engineering ( LTH )

One of Johan Lindvall’s previous positions was as Supply Chain Director for the Nordic countries in Biomet, with responsibility for logistics and customer service. Biomet, now Zimmer Biomet, is a world-leading orthopaedic company.

Johan Lindvall has also been Plant Director and had assignments in European operations for Biomet. He joins Enzymatica from a position as Deputy CEO and Chief Operating Office of Agellis Group, which develops, manufactures and markets measuring instruments and monitoring equipment for the global metal industry.

 

Therese Filmersson
Chief Financial Officer
Born 1969. With Enzymatica since 2018

Therese has long and wide experience as CFO. Therese has been CFO & Vice President of the Procurator Group, one of the leading wholesale companies in the Nordic countries, including protective clothing, sanitary ware and office supplies.

Therese has also worked in areas such as HR, legal, logistics and strategic IT. Before that, Therese was Finance Director of MTG Internet Retailing, CFO of CDON, Business Area Controller at MTG, CFO/operational Finance Manager at TV Shop Europe AB, Controller/HR Manager at Bravida Syd AB and Controller at ABB Installation, Division South.

Carl-Johan Wachtmeister
Acting Communications Manager
Born 1955

Carl-Johan has been hired communications manager since September 2017. Carl-Johan has been information manager for pharmaceutical companies Kabi and Kabi Pharmacia, Deputy CEO of Procordia EuroCentre in Brussels and Information Director, and together with CFO Investor Relations Manager for Atlas Copco. Today, Carl-Johan is an adviser to business management in strategic communication.

This content needs to be approved before viewing.
Yes, I accept
No, I decline